Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00206388
What this trial is testing

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Who this might be right for
NEUROBLASTOMA
Baylor College of Medicine 21
Not applicableUnknownNCT01295762
What this trial is testing

Immunomonitoring of Children With Neuroblastoma

Who this might be right for
Neuroblastoma
Centre Leon Berard 35
Not applicableStudy completedNCT07801560
What this trial is testing

CyberKnife Radiotherapy for the Treatment of Schwannomas

Who this might be right for
Schwannoma, Vestibular
Hartmann Oncology Radiotherapy Group, France 200
Early research (Phase 1)Ended earlyNCT04254107
What this trial is testing

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Who this might be right for
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more
Seagen Inc. 133
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261241
What this trial is testing

NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 118
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Not applicableActive Not RecruitingNCT00924196
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis Type 1Malignant Peripheral Nerve Sheath TumorPlexiform Neurofibroma+2 more
National Cancer Institute (NCI) 259
Early research (Phase 1)Active Not RecruitingNCT04420975
What this trial is testing

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more
Jonsson Comprehensive Cancer Center 14
Not applicableUnknownNCT03970681
What this trial is testing

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Who this might be right for
Neuroma, Acoustic
University Hospital, Strasbourg, France 40
Early research (Phase 1)Study completedNCT00450736
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
University of Miami 3
Not applicableStudy completedNCT03213444
What this trial is testing

Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

Who this might be right for
Colon CancerAdjuvant Chemotherapy
University of Sao Paulo General Hospital 30
Not applicableLooking for participantsNCT06572475
What this trial is testing

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Who this might be right for
Vestibular SchwannomaGlioma, Astrocytic
Northern Care Alliance NHS Foundation Trust 17
Not applicableUnknownNCT05445271
What this trial is testing

Optic Nerve Sheath Diameter in Pediatric Patients

Who this might be right for
Optic Nerve Sheath NeoplasmIntracranial Pressure IncreaseIntubation Complication+1 more
Kahramanmaras Sutcu Imam University 90
Testing effectiveness (Phase 2)Study completedNCT01140360
What this trial is testing

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

Who this might be right for
NeurofibromatosisNeurofibromas
Kent Robertson 21
Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Not applicableUnknownNCT05755295
What this trial is testing

Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma

Who this might be right for
Neuroblastoma
University Hospital, Toulouse 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994
What this trial is testing

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Who this might be right for
NeuroblastomaGD2 AntibodyAutologous NK Cell
Guangzhou Women and Children's Medical Center 15
Early research (Phase 1)Temporarily pausedNCT04539366
What this trial is testing

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

Who this might be right for
Recurrent Childhood NeuroblastomaRecurrent Childhood OsteosarcomaRecurrent Neuroblastoma+5 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Study completedNCT00072358
What this trial is testing

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 291
Next Page